A comparison of severe hemodynamic disturbances between dexmedetomidine and propofol for sedation in neurocritical care patients

Critical Care Medicine

Volumn 42, Issue 7, 2014, Pages 1696-1702

  Erdman, Michael J ^a   Doepker, Bruce A ^b,c   Gerlach, Anthony T ^b,c   Phillips, Gary S ^c   Elijovich, Lucas ^d,e   Jones, G Morgan ^f,g  

^a UNIVERSITY OF FLORIDA HEALTH JACKSONVILLE   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^e SEMMES MURPHEY NEUROLOGIC AND SPINE INSTITUTE   (United States)

^f Methodist Healthcare   (United States)

^g UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

dexmedetomidine; hypotension; intensive care; neurosciences; propofol; sedatives

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; DEXMEDETOMIDINE; DIURETIC AGENT; ENZYME INHIBITOR; GLYCERYL TRINITRATE; HYDRALAZINE; MANNITOL; NITROPRUSSIDE SODIUM; PROPOFOL;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG DOSE TITRATION; DRUG INFUSION; DRUG MEGADOSE; HEART RATE; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPENSITY SCORE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SEDATION; TREATMENT DURATION; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRADYCARDIA; CRITICAL CARE; DEXMEDETOMIDINE; FEMALE; HEALTH STATUS INDICATORS; HEMODYNAMICS; HUMANS; HYPNOTICS AND SEDATIVES; HYPOTENSION; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PREVALENCE; PROPOFOL; RETROSPECTIVE STUDIES;

EID: 84902535374     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000328     Document Type: Article

References (35)

1. Mazzeo AJ: Sedation for the mechanically ventilated patient. Crit Care Clin 1995; 11:937-955
2. Barr J, Fraser GL, Puntillo K, et al; American College of Critical Care Medicine: Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013; 41:263-306
3. Makii JM, Mirski MA, Lewin JJ 3rd: Sedation and analgesia in critically ill neurologic patients. J Pharm Pract 2010; 23:455-469
4. Egerod I, Jensen MB, Herling SF, et al: Effect of an analgo-sedation protocol for neurointensive patients: A two-phase interventional non-randomized pilot study. Crit Care 2010; 14:R71
5. Hutchens MP, Memtsoudis S, Sadovnikoff N: Propofol for sedation in neuro-intensive care. Neurocrit Care 2006; 4:54-62
6. Winchell RJ, Simons RK, Hoyt DB: Transient systolic hypotension. A serious problem in the management of head injury. Arch Surg 1996; 131:533-539
7. Chesnut RM, Marshall SB, Piek J, et al: Early and late systemic hypotension as a frequent and fundamental source of cerebral ischemia following severe brain injury in the Traumatic Coma Data Bank. Acta Neurochir Suppl (Wien) 1993; 59:121-125
8. Claeys MA, Gepts E, Camu F: Haemodynamic changes during anaesthesia induced and maintained with propofol. Br J Anaesth 1988; 60:3-9
9. Jakob SM, Ruokonen E, Grounds RM, et al; Dexmedetomidine for Long-Term Sedation Investigators: Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: Two randomized controlled trials. JAMA 2012; 307:1151-1160
10. Anger KE, Szumita PM, Baroletti SA, et al: Evaluation of dexmedetomidine versus propofol-based sedation therapy in mechanically ventilated cardiac surgery patients at a tertiary academic medical center. Crit Pathw Cardiol 2010; 9:221-226
11. APP Pharmaceuticals, LLC: Propofol [package insert]. Schaumburg, IL, APP Pharmaceuticals, LLC
12. Chaudhri S, Kenny GN: Sedation after cardiac bypass surgery: Comparison of propofol and midazolam in the presence of a computerized closed loop arterial pressure controller. Br J Anaesth 1992; 68:98-99
13. Annecke T, Conzen P, Ney L: Propofol-related infusion syndrome induced by "moderate dosage" in a patient with severe head trauma. J Clin Anesth 2012; 24:51-54
14. Hospira: Dexmedetomidine [package insert]. Lake Forest, IL, Hospira
15. Grof TM, Bledsoe KA: Evaluating the use of dexmedetomidine in neurocritical care patients. Neurocrit Care 2010; 12:356-361
16. Wunsch H, Kahn JM, Kramer AA, et al: Use of intravenous infusion sedation among mechanically ventilated patients in the United States. Crit Care Med 2009; 37:3031-3039
17. Bhana N, Goa KL, McClellan KJ: Dexmedetomidine. Drugs 2000; 59:263-268; discussion 269-270
18. Gerlach AT, Dasta JF: Dexmedetomidine: An updated review. Ann Pharmacother 2007; 41:245-252
19. Devabhakthuni S, Pajoumand M, Williams C, et al: Evaluation of dexmedetomidine: Safety and clinical outcomes in critically ill trauma patients. J Trauma 2011; 71:1164-1171
20. Mirski MA, Lewin JJ 3rd, Ledroux S, et al: Cognitive improvement during continuous sedation in critically ill, awake and responsive patients: The Acute Neurological ICU Sedation Trial (ANIST). Intensive Care Med 2010; 36:1505-1513
21. Aryan HE, Box KW, Ibrahim D, et al: Safety and efficacy of dexmedetomidine in neurosurgical patients. Brain Inj 2006; 20:791-798
22. Gerlach AT, Dasta JF, Steinberg S, et al: A new dosing protocol reduces dexmedetomidine-Associated hypotension in critically ill surgical patients. J Crit Care 2009; 24:568-574
23. Jones GM, Murphy CV, Gerlach AT, et al: High-dose dexmedetomidine for sedation in the intensive care unit: An evaluation of clinical efficacy and safety. Ann Pharmacother 2011; 45:740-747
24. Gerlach A, Blais D, Jones G, et al: 128: High dose dexmedetomidine is not associated with increased risk of hypotension. Crit Care Med 2012; 40(Suppl 1):1-328
25. Jones GM, Doepker BA, Erdman MJ, et al: Predictors of severe hypotension in neurocritical care patients sedated with propofol. Neurocrit Care 2014; 20:270-276
26. Edwin L, Barbara S: PSMATCH2: Stata Module to Perform Full Mahalanobis and Propensity Score Matching, Common Support Graphing, and Covariate Imbalance Testing. Boston College Department of Economics, Chestnut Hill, MA, 2003
27. Venn RM, Grounds RM: Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: Patient and clinician perceptions. Br J Anaesth 2001; 87:684-690
28. Venn RM, Bradshaw CJ, Spencer R, et al: Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999; 54:1136-1142
29. Riker RR, Shehabi Y, Bokesch PM, et al; SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group: Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial. JAMA 2009; 301:489-499
30. Pandharipande PP, Pun BT, Herr DL, et al: Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: The MENDS randomized controlled trial. JAMA 2007; 298:2644-2653
31. Herr DL, Sum-Ping ST, England M: ICU sedation after coronary artery bypass graft surgery: Dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth 2003; 17:576-584
32. Elbaradie S, El Mahalawy FH, Solyman AH: Dexmedetomidine vs. propofol for short-term sedation of postoperative mechanically ventilated patients. J Egypt Natl Canc Inst 2004; 16:153-158
33. Venn RM, Karol MD, Grounds RM: Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth 2002; 88:669-675
34. Ebert TJ, Hall JE, Barney JA, et al: The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93:382-394
35. Biccard BM, Goga S, de Beurs J: Dexmedetomidine and cardiac protection for non-cardiac surgery: A meta-Analysis of randomised controlled trials. Anaesthesia 2008; 63:4-14